Introducing CleraFlex™, the world’s first stretchable wound dressing. Today, GelSana is proud to bring CleraFlex to market. Chronic and difficult-to-heal wounds including diabetic foot ulcers, pressure injuries, venous leg ulcers, surgical incisions, and second-degree burns affect tens of millions of…
We’re proud to share that GelSana was featured in a segment by Colorado Public Radio, highlighting the science behind CleraFlex and the clinical need it addresses. Reporter Andrea Dukakis spoke with our founder, Dr. Melissa Krebs, about the technology and…
Medtech Industry Veteran joins GelSana as Chief Commercial Officer (AURORA, CO) – January 09, 2026 – GelSana Therapeutics, Inc. (“GelSana”), a wound care company developing novel polymer-based dressings to accelerate healing, today announced that Donald Gregg has joined the company…
We were featured on KUSA-TV, 9NEWS! Proud to see GelSana and Colorado School of Mines featured, sharing our translation of advanced materials for tackling one of the most persistent challenges in healthcare: healing and recovery for difficult-to-heal wounds. This…
GelSana was featured on the Nasdaq tower in Times Square along with all of the other amazing 2025 MedTech Innovator companies as we celebrated graduating from the accelerator program.
GelSana is thrilled to have been selected to participate in Plug and Play Tech Center‘s Medtech Accelerator! We are excited to make new connections and continue to push GelSana forward through the partner engagement, networking, and mentorship. WARSAW, IN…
Melissa Krebs presented on a panel at The MedTech Conference by AdvaMed, sponsored by MedTech Innovator to discuss Hydrogels & Wound Healing Tech with other MTI startup companies in this area, moderated by Skander Limem, Ph.D. of Becton Dickinson (BD).…
We’re In! GelSana Therapeutics, Inc. Joins the 2025 MedTech Innovator Cohort We’re proud to share that GelSana Therapeutics, Inc. has been selected to join the 2025 MedTech Innovator cohort, the world’s largest accelerator for medical device companies. GelSana is one of…
Melissa Krebs, CEO, has been inducted into the American Institute for Medical and Biological Engineering College of Fellows. AIMBE membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new…
GelSana is proud to announce that we have been awarded another NIH SBIR Phase I funding through the NIDDK for the development of a polymer designed for the sustained delivery of a therapeutic growth factor to treat diabetic foot ulcers.…
